Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Bull Exp Biol Med ; 176(2): 253-259, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38198101

ABSTRACT

We studied the effect of exosomes derived from mesenchymal stem cells on the synthesis of collagen I and α-smooth muscle actin (α-SMA) by rat fibroblast culture. Exosomes were isolated from the verified culture of mesenchymal stem cells and also verified. Fibrosis was modeled using a fibroblast culture supplemented with recombinant TGF-ß1 (5 ng/ml) and immunocytochemical analysis of the expression of collagen I and α-SMA markers was carried out. After 6-day incubation, the expression of the studied markers increased in comparison with the control. Addition of exosomes to the fibroblast culture reduced the production of collagen and SMA, which allows considering exosomes as a promising drug for the treatment of pathologies associated with fibrosis.


Subject(s)
Exosomes , Mesenchymal Stem Cells , Rats , Animals , Exosomes/metabolism , Fibrosis , Transforming Growth Factor beta1/genetics , Transforming Growth Factor beta1/metabolism , Collagen Type I/genetics , Collagen Type I/metabolism , Collagen/metabolism , Mesenchymal Stem Cells/metabolism
2.
Bull Exp Biol Med ; 173(1): 114-118, 2022 May.
Article in English | MEDLINE | ID: mdl-35622252

ABSTRACT

Neurotrophin-3 enhances the effectiveness of human olfactory ensheathing cells in improving hind limb mobility in rats with post-traumatic cysts of the spinal cord. Transplantation of olfactory ensheathing cells into spinal cord cysts reduced their size; neurotrophin-3 did not modulate this effect. Combined preparation of human olfactory ensheathing cells and neurotrophin- 3 can be used in neurosurgery for the treatment of patients with spinal cord injuries.


Subject(s)
Cell- and Tissue-Based Therapy , Cysts , Neurotrophin 3 , Spinal Cord Injuries , Animals , Cell Transplantation , Cysts/therapy , Humans , Nerve Growth Factors/genetics , Nerve Regeneration , Neurotrophin 3/pharmacology , Rats , Spinal Cord , Spinal Cord Injuries/therapy
3.
Bull Exp Biol Med ; 171(1): 122-126, 2021 May.
Article in English | MEDLINE | ID: mdl-34046791

ABSTRACT

We studied the effect of transplantation of ensheathing cells obtained from the olfactory mucosa of rats and humans on the size of posttraumatic spinal cord cysts. MRI examination showed that transplantation of these cells into experimental posttraumatic cysts of the spinal cord led to a significant decrease in cyst volume and even their complete disappearance in two animals receiving transplantation of rat or human cells. These findings attested to regenerative processes developing as a result of ensheathing cell transplantation. Further studies in this field will be aimed at elucidation of the mechanisms underlying spinal cord regeneration in the area of posttraumatic cysts after transplantation of ensheathing cells.


Subject(s)
Cysts , Spinal Cord Injuries , Animals , Cell Transplantation , Nerve Regeneration , Olfactory Bulb , Olfactory Mucosa , Rats , Spinal Cord , Spinal Cord Injuries/therapy
4.
Bull Exp Biol Med ; 168(4): 538-541, 2020 Feb.
Article in English | MEDLINE | ID: mdl-32157509

ABSTRACT

We studied the efficiency of transplantation of neural stem/progenitor cells from human olfactory mucosa in chronic spinal cord injury. Neural stem/progenitor cells were obtained by a protocol modified by us and transplanted to rats with spinal post-traumatic cysts. It was shown that transplantation of neural stem/progenitor cells from human olfactory lining improved motor activity of hind limbs in the recipient rat with spinal post-traumatic cysts (according to BBB scale).


Subject(s)
Motor Activity/physiology , Neural Stem Cells/transplantation , Recovery of Function , Spinal Cord Injuries/therapy , Stem Cell Transplantation , Animals , Chronic Disease , Hindlimb , Humans , Nasal Cavity/cytology , Nasal Cavity/surgery , Neural Stem Cells/cytology , Neural Stem Cells/physiology , Olfactory Mucosa/cytology , Olfactory Mucosa/surgery , Primary Cell Culture , Rats , Rats, Wistar , Spinal Cord/surgery , Spinal Cord Injuries/pathology , Spinal Cord Injuries/surgery , Transplantation, Heterologous
5.
Bull Exp Biol Med ; 169(4): 539-543, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32910386

ABSTRACT

In experiments on rats, co-transplantation of olfactory ensheathing cells of the human olfactory mucosa and neural stem/progenitor cells from the same source into post-traumatic cysts of the spinal cord led to improvement of the motor activity of the hind limbs and reduced the size of the cysts in some animals by 4-12%. The transplantation of a combination of the olfactory mucosa cells is effective and can be used in preclinical trials for the treatment of spinal cord injuries.


Subject(s)
Cysts/therapy , Epithelial Cells/transplantation , Neural Stem Cells/transplantation , Recovery of Function/physiology , Spheroids, Cellular/transplantation , Spinal Cord Injuries/therapy , Animals , Cell- and Tissue-Based Therapy/methods , Cysts/pathology , Cysts/physiopathology , Epithelial Cells/cytology , Epithelial Cells/physiology , Female , Humans , Motor Activity/physiology , Neural Stem Cells/cytology , Neural Stem Cells/physiology , Olfactory Mucosa/cytology , Olfactory Mucosa/physiology , Primary Cell Culture , Rats , Rats, Wistar , Spheroids, Cellular/cytology , Spheroids, Cellular/physiology , Spinal Cord/pathology , Spinal Cord/physiopathology , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Transplantation, Heterologous , Treatment Outcome
6.
Bull Exp Biol Med ; 170(1): 158-163, 2020 Nov.
Article in English | MEDLINE | ID: mdl-33231802

ABSTRACT

In this work, an optimal protocol was developed for obtaining adhesion culture of neural stem/progenitor cells (NSPC) of rat olfactory mucosa. During the development of the protocol, the conditions for cell culturing on adhesion substrates fibronectin and laminin in DMEM/F-12 and neurobasal media with the same culture additives were compared. Cell proliferation was maximum during culturing on both substrates in the neurobasal medium. Using the immunofluorescence method, we found that culturing on fibronectin in the neurobasal medium ensured maximum (52.22%) content of nestin-positive cells in comparison with other culturing conditions. The highest percentage of ßIII-tubulin-positive cells was detected in cultures growing on fibronectin in the neurobasal medium and in DMEM/F-12 (79.11 and 83.52%, respectively). Culturing in adhesion cultures in the neurobasal medium on fibronectin allowed obtaining cultures enriched with NSPC and neurons differentiating from them in a quantity sufficient for further transplantation. The developed protocol can be recommended for obtaining NPSC from human olfactory mucosa for the treatment of spinal cord injuries.


Subject(s)
Cell- and Tissue-Based Therapy/methods , Culture Media/pharmacology , Neural Stem Cells/cytology , Neurons/cytology , Olfactory Mucosa/cytology , Animals , Biomarkers/metabolism , Cell Adhesion/drug effects , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Culture Media/chemistry , Fibronectins/pharmacology , Gene Expression/drug effects , Humans , Laminin/pharmacology , Nestin/genetics , Nestin/metabolism , Neural Stem Cells/drug effects , Neural Stem Cells/metabolism , Neurons/drug effects , Neurons/metabolism , Olfactory Mucosa/drug effects , Olfactory Mucosa/metabolism , Primary Cell Culture , Rats , Rats, Wistar , Spinal Cord Injuries/therapy , Tubulin/genetics , Tubulin/metabolism
7.
Bull Exp Biol Med ; 168(5): 658-661, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32246376

ABSTRACT

Reduced expression of the key regulator of cardiac metabolism, transcription factor PPARα, in surgical samples of the auricles from patients with coronary heart disease and heart failure was detected by real-time quantitative PCR. These changes indicate reduced activity of this factor and a shift of energy metabolism from oxidative phosphorylation to glycolysis typical of dedifferentiated cells. Electron microscopy revealed dedifferentiated cardiomyocytes with disassembled contractile apparatus and disorganized sarcomeres. In the examined specimens from patients with heart failure, severe myocardial fibrosis was revealed.


Subject(s)
Energy Metabolism/physiology , Heart/physiology , Myocytes, Cardiac/metabolism , PPAR alpha/physiology , Regeneration/physiology , Biopsy , Cell Dedifferentiation/genetics , Coronary Disease/genetics , Coronary Disease/metabolism , Coronary Disease/pathology , Coronary Disease/physiopathology , Endomyocardial Fibrosis/genetics , Endomyocardial Fibrosis/metabolism , Endomyocardial Fibrosis/pathology , Endomyocardial Fibrosis/physiopathology , Energy Metabolism/genetics , Gene Expression Regulation , Glycolysis/genetics , Heart Failure/genetics , Heart Failure/metabolism , Heart Failure/pathology , Heart Failure/physiopathology , Humans , Myocardium/metabolism , Myocardium/pathology , Myocytes, Cardiac/pathology , Myocytes, Cardiac/physiology , Oxidative Phosphorylation , PPAR alpha/genetics , PPAR alpha/metabolism
8.
Bull Exp Biol Med ; 168(1): 118-124, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31758381

ABSTRACT

We studied the effect of IL-1ß on the permeability of brain capillaries in healthy mice. Intravital microscopy demonstrated that parenteral administration of IL-1ß was followed by an increase in vascular permeability ensuring passage of free Alexa488 fluorescent label through the capillary walls, but not sufficient for penetration of liposomes. In addition, experiments on mice with intracranial M6 glioma showed penetration of liposomes through the walls of tumor capillaries after parenteral administration of IL-1ß in a concentration of 2 µg/ml. Thus, the use of proinflammatory cytokine IL-1ß in the therapy of brain tumors can significantly increase the therapeutic efficacy of drug delivery systems, in particular, for drugs poorly crossing the blood-brain barrier.


Subject(s)
Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Glioma/metabolism , Interleukin-1beta/pharmacology , Intravital Microscopy/methods , Animals , Biological Transport/physiology , Cell Line, Tumor , Disease Models, Animal , Female , Liposomes/metabolism , Mice , Mice, Inbred C57BL
9.
Bull Exp Biol Med ; 167(4): 536-540, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31502130

ABSTRACT

Olfactory ensheathing cells showed significant effects on the regeneration of the spinal cord in experimental models and in clinical trials. However, the use of these cells in the therapy of posttraumatic cysts of the spinal cord has not been studied. Cultures of human and rat olfactory mucosa were obtained according to the protocols developed by us. Passage 3-4 cultures are most enriched with olfactory ensheathing cells and are preferable for transplantation. We performed transplantation of 750,000 olfactory ensheathing cells into the region of modeled cysts. The therapeutic effect of human cells was more pronounced. The positive dynamics of recovery of motor activity in the hind limbs of rats can reflect regenerative processes in the spinal cord after transplantation of olfactory ensheathing cells into the region of posttraumatic cysts.


Subject(s)
Cell- and Tissue-Based Therapy/methods , Olfactory Mucosa/cytology , Spinal Cord Injuries/therapy , Animals , Cells, Cultured , Female , Humans , Nerve Regeneration/physiology , Rats , Rats, Wistar , Recovery of Function/physiology
10.
Vestn Otorinolaringol ; 84(1): 31-35, 2019.
Article in Russian | MEDLINE | ID: mdl-30938339

ABSTRACT

The olfactory epithelium (OE) is an accessible source of neural stem cells and progenitor cells. The objective of the study was to compare the effectiveness of various biopsy sites to isolate and propagate neural progenitor cells from the olfactory epithelium (OE). The authors assessed OE cell count in OE in different sites of the nasal cavity and showed the possibility of isolation neurospheres from nasal biopsies. In total, 45 inpatinets were included in the study. Biopsy specimens were obtained from 30 patients undergoing septoplasty and/or turbinate surgery. Three areas of OE were biopsied: lower third section of the nasal septum (A), anterior part of the middle turbinate (B), upper third of the nasal septum (C). Immunocytochemistry and fluorescence-activated cell sorting showed that OE cells were NCAM-positive. Mean percentage of NCAM+ cells was 7.8% for A, 42.7% for B and 18.2% for C. The difference was significant between A and B (p=0.0001) and B and C (p=0.01). Therefore, the anterior part of the middle turbinate was an easily accessible and safe site to obtain neural cells. To confirm this, neurospheres were obtained in 15 patients with schizophrenia who underwent in-office endoscopy.


Subject(s)
Neural Stem Cells , Olfactory Mucosa , Humans , Nasal Cavity , Neurons , Turbinates
11.
Bull Exp Biol Med ; 165(1): 132-135, 2018 May.
Article in English | MEDLINE | ID: mdl-29796806

ABSTRACT

We evaluated the efficacy of rat olfactory ensheathing cells in the therapy of experimental cysts of the spinal cord. Improvement of the motor function of the hind limbs after transplantation of the olfactory ensheathing cells into the posttraumatic spinal cord cysts rats was found. We also determined the required number of cells for transplantation and demonstrated a neuroprotective effect of this dosage. For further clinical studies, autologous tissue-specific cell preparation of olfactory ensheathing cells has to be created. Cell therapy in combination surgical and pharmacological treatment will substantially improve the quality of life of patients with posttraumatic spinal cord cysts.


Subject(s)
Cysts/therapy , Olfactory Bulb/cytology , Spinal Cord Injuries/therapy , Animals , Female , Nerve Regeneration/physiology , Rats , Rats, Wistar , Recovery of Function/physiology , Spinal Cord/physiology
12.
Bull Exp Biol Med ; 164(4): 523-527, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29504110

ABSTRACT

We developed an optimal protocol for preparing and culturing of olfactory ensheathing cells from human olfactory mucosa. Using this protocol, we obtained a culture enriched with human olfactory ensheathing cells. Immunofluorescence analysis by simultaneous expression of GFAP and p75NTR markers showed that the content of ensheathing cells was maximum in passage 3 and 4 cultures (94 and 89.5%, respectively). The developed protocol can be recommended for obtaining autologous preparations of human ensheathing cells for cell therapy of spinal cord injuries.


Subject(s)
Cell- and Tissue-Based Therapy/methods , Olfactory Bulb/cytology , Olfactory Mucosa/cytology , Primary Cell Culture/methods , Biomarkers/metabolism , Cell Proliferation , Gene Expression , Glial Fibrillary Acidic Protein/genetics , Glial Fibrillary Acidic Protein/metabolism , Humans , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Olfactory Bulb/metabolism , Olfactory Bulb/surgery , Olfactory Mucosa/metabolism , Olfactory Mucosa/surgery , Receptors, Nerve Growth Factor/genetics , Receptors, Nerve Growth Factor/metabolism , Spinal Cord Injuries/therapy
13.
Bull Exp Biol Med ; 166(1): 118-123, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30417294

ABSTRACT

We studied survival of rat ensheathing cells after transplantation into experimental posttraumatic cysts. These cells were prepared according to our original protocol, labeled with intravital membrane dye PKH26, and transplanted into posttraumatic cysts of the spinal cord. The presence of cysts was verified by magnetic resonance imaging. Olfactory ensheathing cells were detected in the spinal cord by the immunofluorescence method. It was shown that rat olfactory ensheathing cells survived in the spinal cord over 4 weeks and their migration was observed. High survival rate and the possibility of obtaining olfactory ensheathing cells from the olfactory mucosa of patients for creation of an autologous preparation allow considering them as very promising material for the treatment of patients with posttraumatic cysts of the spinal cord.


Subject(s)
Cysts/therapy , Olfactory Mucosa/cytology , Spinal Cord Injuries/therapy , Animals , Cell Survival/physiology , Cell- and Tissue-Based Therapy , Nerve Regeneration/physiology , Rats
14.
Bull Exp Biol Med ; 164(6): 794-797, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29658071

ABSTRACT

Pathological remodeling of the myocardium in chronic heart failure includes the development of pathological cardiac hypertrophy, reactivation of the fetal genetic program, and disorders in cardiac energy metabolism. Coactivator-1α of receptor γ activated by peroxisome proliferator (PGC-1α), a transcription coactivator of nuclear receptors and metabolism master regulator, plays an important role in cardiac metabolism regulation. Studies on the animals models of chronic heart failure have demonstrated the development of pathological cardiac hypertrophy, metabolic disorders, and reactivation of the fetal genetic program; these processes are mutually related. An important role in regulation of these processes belongs to PGC-1α; its low expression indicates low activity and down-regulation of this coactivator. Pathological cardiac hypertrophy, decrease of PGC-1α activity, and reactivation of the fetal genetic program in chronic heart failure are demonstrated.


Subject(s)
Cardiomegaly/genetics , Cardiomyopathy, Dilated/genetics , Heart Failure/genetics , Myocardium/metabolism , Myocytes, Cardiac/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/genetics , Adult , Cardiomegaly/metabolism , Cardiomegaly/physiopathology , Cardiomyopathy, Dilated/metabolism , Cardiomyopathy, Dilated/physiopathology , Case-Control Studies , Female , Fetus , Gene Expression Regulation , Heart Failure/metabolism , Heart Failure/physiopathology , Humans , Male , Middle Aged , Myocardium/pathology , Myocytes, Cardiac/pathology , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/metabolism , Primary Cell Culture
SELECTION OF CITATIONS
SEARCH DETAIL